IQGAP2 and neoplasm: The tumor weight and tumor volume in the ALDH9A1-overexpressing group were significantly decreased, while the additional knockdown of IQGAP2 reversed this inhibition caused by ALDH9A1 overexpression (Fig. 8B, C).